Kirjojen hintavertailu. Mukana 12 390 323 kirjaa ja 12 kauppaa.

Kirjailija

Robert L Hirsch

Kirjat ja teokset yhdessä paikassa: 5 kirjaa, julkaisuja vuosilta 2006-2022, suosituimpien joukossa Impending World Energy Mess. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

5 kirjaa

Kirjojen julkaisuhaarukka 2006-2022.

Impending World Energy Mess

Impending World Energy Mess

Robert L Hirsch; Roger H Bezdek; Robert M Wendling

Griffin Media
2010
nidottu
This book will help to educate readers about the realities of energy in general and oil in particular. The reader will be able to cut through the smokescreens that various self interests have, and are promulgating and understand that there are a number of credible studies that clearly demonstrate that world oil production is close to going into decline, which will create long-term world oil shortages. The huge economic impacts associated with impending oil shortages are brought into sober, balanced perspective and readers are given tools to minimise the impending negative impacts on their personal lives. Finally, the book provides a balanced discussion of the strengths and weaknesses of a number of electric power production technologies, and in particular, the inherent weaknesses in solar and renewable technologies.
Peaking of World Oil Production

Peaking of World Oil Production

Robert L Hirsch; Roger Bezdek; Robert Wendling

Nova Science Publishers Inc
2006
nidottu
The peaking of world oil production presents the U.S. and the world with an unprecedented risk management problem. As peaking is approached, liquid fuel prices and price volatility will increase dramatically, and without timely mitigation, the economic, social, and political costs will be unprecedented. Viable mitigation options exist on both the supply and demand sides, but to have substantial impact, they must be initiated more than a decade in advance of peaking. Dealing with world oil production peaking will be extremely complex, involve literally trillions of dollars and require many years of intense effort. To explore these complexities, three alternative mitigation scenarios are analysed: scenario I assumes that action is not initiated until peaking occurs; scenario II assumes that action is initiated 10 years before peaking; scenario III assumes action is initiated 20 years before peaking. For this analysis estimates of the possible contributions of each mitigation option were developed, based on an assumed crash program rate of implementation.
Invisible Threat

Invisible Threat

Robert L Hirsch

iUniverse
2020
sidottu
Dr. Alan Mazer graduated from Harvard Medical School at the age of twenty and started curing rare diseases by age twenty-five. He grew into one of America's most brilliant scientists, so no one could have foreseen his true intentions. Now a radicalized Muslim, Mazer uses his genius to isolate viruses that attack the nervous system. One "vaccine" kills instead of protecting, stealing the lives of children. In particular, Mazer targets Israelis and Americans in an effort to bring down Western society. Now, skilled Mossad agents, the Joint Terrorist Task Force, and an immunologist from a biotechnology company work together to fight against jihad. They rush to stop Mazer and his team of terrorists, even as unlimited funds roll in from across the globe supporting Mazer's cause. This team must find this man and stop him before the virus and others spread indiscriminately.
Invisible Threat

Invisible Threat

Robert L Hirsch

iUniverse
2020
pokkari
Dr. Alan Mazer graduated from Harvard Medical School at the age of twenty and started curing rare diseases by age twenty-five. He grew into one of America's most brilliant scientists, so no one could have foreseen his true intentions. Now a radicalized Muslim, Mazer uses his genius to isolate viruses that attack the nervous system. One "vaccine" kills instead of protecting, stealing the lives of children. In particular, Mazer targets Israelis and Americans in an effort to bring down Western society. Now, skilled Mossad agents, the Joint Terrorist Task Force, and an immunologist from a biotechnology company work together to fight against jihad. They rush to stop Mazer and his team of terrorists, even as unlimited funds roll in from across the globe supporting Mazer's cause. This team must find this man and stop him before the virus and others spread indiscriminately.